New & Noteworthy

October 2015

PCR for Cancer Mutations

EKF Diagnostics

EKF Molecular's portfolio of PointMan DNA enrichment products includes BRAF, KRAS, EGFR, NRAS, and JAK2. PointMan is a real-time polymerase chain reaction (PCR) technology that provides reliable and sensitive detection for cancer mutations. It is efficient in amplifying the target sequence of interest, while suppressing amplification of the wild-type. The resulting sample is effectively enriched for the mutation, thereby having the potential to offer sensitivity in a wide variety of sample types, including whole blood. Such sensitivity offers an advantage in the early detection and monitoring of disease progression, as well as in assessing the efficacy of ongoing anti-cancer treatments without the need for tissue biopsy.

Request More Information

Current Issue